CINECA IRIS Institutional Research Information System

This phase II study was designed to assess the activity and tolerability of the carboplatin-paclitaxel combination, given without routine growth factor support to previously untreated patients with stage IIIB and IV non-small cell lung cancer.

Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer

Novello, S;GALLI, Loris;Pozzi, E;Scagliotti, GV
2001-01-01

Abstract

This phase II study was designed to assess the activity and tolerability of the carboplatin-paclitaxel combination, given without routine growth factor support to previously untreated patients with stage IIIB and IV non-small cell lung cancer.
2001
LUNG CANCER
34
2
261
269
Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Survival Analysis
Novello, S; Galli, L; Antonuzzo, A; Crinó, L; Pozzi, E; Selvaggi, G; Ricci, S; Marrocolo, F; Darwish, S; Sorbolini, S; Tonato, M; Scagliotti, GV
03A-Articolo su Rivista
File in questo prodotto:
File Dimensione Formato  
PII_ S0169-5002(01)00238-0.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 95.93 kB
Formato Adobe PDF
  Visualizza/Apri   Richiedi una copia
95.93 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1691301
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact